Form 4: Lyell Immunopharma CEO Sells Shares
Insider Transaction (Form 4)
Lynn Seely, President and CEO and a Director of Lyell Immunopharma, Inc., sold 390 shares of common stock on August 10, 2026 for $14.34 per share.
Summary
- Open-market sale: disposed of 390 Common Stock at $14.34 ($5,593) on August 10, 2026; holds 73,488 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $5,593 of stock on the open market.
Insider Transactions
Lynn Seely — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | Common Stock | 390 | $14 | $5.6K | 73,488 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (390 shares) |
Keywords
insider transaction, Form 4, LYEL, Lyell Immunopharma, Inc., bearish, Lynn Seely
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.